...
首页> 外文期刊>World journal of gastroenterology : >Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy.
【24h】

Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy.

机译:多学科团队治疗对胃肠道恶性肿瘤患者预后的影响。

获取原文
获取原文并翻译 | 示例

摘要

AIM: To evaluate the effect of multidisciplinary team (MDT) treatment modality on outcomes of patients with gastrointestinal malignancy in China. METHODS: Data about patients with gastric and colorectal cancer treated in our center during the past 10 years were collected and divided into two parts. Part 1 consisted of the data collected from 516 consecutive complicated cases discussed at MDT meetings in Peking University School of Oncology (PKUSO) from December 2005 to July 2009. Part 2 consisted of the data collected from 263 consecutive cases of resectable locally advanced rectal cancer from January 2001 to January 2005. These 263 patients were divided into neoadjuvant therapy (NT) group and control group. Patients in NT group received MDT treatment, namely neoadjuvant therapy + surgery + postoperative adjuvant therapy. Patients in control group underwent direct surgery + postoperative adjuvant therapy. The outcomes in two groups were compared. RESULTS: The treatment strategy was altered after discussed at MDT meeting in 76.81% of gastric cancer patients and in 58.33% of colorectal cancer patients before operation. The sphincter-preservation and local control of tumor were better in NT group than in control group. The 5-year overall survival rate was also higher in NT group than in control group (77.23% vs 69.75%, P = 0.049). CONCLUSION: MDT treatment modality can significantly improve the outcomes of patients with gastrointestinal malignancy in China.
机译:目的:评估多学科团队(MDT)治疗方式对中国胃肠道恶性肿瘤患者预后的影响。方法:收集过去十年来我中心收治的胃癌和结直肠癌患者的数据,分为两部分。第1部分包含从2005年12月至2009年7月在北京大学肿瘤医学院(PKUSO)的MDT会议上讨论的516例连续性复杂病例收集的数据。第2部分包括从263例可切除的局部晚期直肠癌连续病例中收集的数据2001年1月至2005年1月。将这263例患者分为新辅助治疗(NT)组和对照组。 NT组患者接受了MDT治疗,即新辅助治疗+手术+术后辅助治疗。对照组患者接受直接手术加术后辅助治疗。比较两组的结果。结果:在MDT会议上讨论后,手术前76.81%的胃癌患者和58.33%的大肠癌患者改变了治疗策略。 NT组的括约肌保留和肿瘤的局部控制优于对照组。 NT组的5年总生存率也高于对照组(77.23%vs 69.75%,P = 0.049)。结论:MDT治疗方式可以显着改善中国胃肠道恶性肿瘤的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号